373 related articles for article (PubMed ID: 3121819)
21. Utility of surveillance biopsies in infant heart transplant recipients.
Balzer DT; Moorhead S; Saffitz JE; Huddleston CB; Spray TL; Canter CE
J Heart Lung Transplant; 1995; 14(6 Pt 1):1095-101. PubMed ID: 8719456
[TBL] [Abstract][Full Text] [Related]
22. Heart-lung transplantation: the initial Arizona experience.
Rhenman B; Rhenman MJ; Icenogle TB; Vasu MA; Sethi GK; Rosado LJ; Williams R; Copeland J
J Thorac Cardiovasc Surg; 1989 Nov; 98(5 Pt 2):922-7. PubMed ID: 2554069
[TBL] [Abstract][Full Text] [Related]
23. Reversal of cardiac transplant rejection without massive immunosuppression.
Michler RE; Smith CR; Drusin RE; Reison DS; Hickey TJ; Lamb J; Reemtsma K; Rose EA
Circulation; 1986 Nov; 74(5 Pt 2):III68-71. PubMed ID: 3533317
[TBL] [Abstract][Full Text] [Related]
24. Effects of prophylactic rabbit antithymocyte globulin in cardiac allograft recipients treated with cyclosporine.
Kawaguchi A; Szentpetery S; Mohanakumar T; Barnhart GR; Lower RR
J Heart Transplant; 1987; 6(4):214-7. PubMed ID: 3312532
[TBL] [Abstract][Full Text] [Related]
25. Comparison of immunosuppression therapy following heart transplantation: pretransfusion/azathioprine/ATG/prednisone versus cyclosporine/prednisone.
Barnhart GR; Goldman MH; Hastillo A; Szentpetery S; Wolfgang T; Thompson J; Mohanakumar T; Katz MR; Rider S; Hanrahan J
J Heart Transplant; 1985; 4(4):381-4. PubMed ID: 3916511
[TBL] [Abstract][Full Text] [Related]
26. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat).
Koch A; Daniel V; Dengler TJ; Schnabel PA; Hagl S; Sack FU
J Heart Lung Transplant; 2005 Jun; 24(6):708-13. PubMed ID: 15949731
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic immunosuppression in cardiac transplantation.
Robinson JA; O'Connell JB
Ann Clin Lab Sci; 1986; 16(3):209-13. PubMed ID: 3521445
[TBL] [Abstract][Full Text] [Related]
28. Benefits of avoidance of induction immunosuppression in heart transplantation.
Menkis AH; McKenzie FN; Thomson D; Jones M; Pflugfelder P; Kostuk WJ; Stiller CR
J Heart Transplant; 1989; 8(4):311-4. PubMed ID: 2671316
[TBL] [Abstract][Full Text] [Related]
29. A randomized study comparing deflazacort and prednisone in heart transplant patients.
Arizón JM; Anguita M; Vallés F; López-Rubio F; López-Granados A; Casares J; Segura J; Mesa D; Muñoz I; Alados P
J Heart Lung Transplant; 1993; 12(5):864-8. PubMed ID: 8241229
[TBL] [Abstract][Full Text] [Related]
30. [The effect of cyclosporin on renal function following cardiac transplantation: should one lessen the toxicity?].
Carrier M; Pelletier GB; Leclerc Y; Castonguay YR; Solymoss BC; Pelletier LC
Can J Surg; 1990 Jun; 33(3):243-7. PubMed ID: 2350751
[TBL] [Abstract][Full Text] [Related]
31. Heart-lung xenotransplantation in primates.
Sadeghi AM; Laks H; Drinkwater DC; Pearl JM; Chang P; Haas G; Burnison CM; Horton D
J Heart Lung Transplant; 1991; 10(3):442-7; discussion 447-8. PubMed ID: 1854771
[TBL] [Abstract][Full Text] [Related]
32. Comparison of Neoral and Sandimmune cyclosporine for induction of immunosuppression after heart transplantation.
Carrier M; White M; Pellerin M; Pelletier GB; Pelletier LC
Can J Cardiol; 1997 May; 13(5):469-73. PubMed ID: 9179085
[TBL] [Abstract][Full Text] [Related]
33. Induction therapy with cyclosporine without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients.
Jazzar A; Fagiuoli S; Sisson S; Zuhdi N; Cooper DK
Clin Transplant; 1995 Aug; 9(4):334-9. PubMed ID: 7579743
[TBL] [Abstract][Full Text] [Related]
34. Increased rejection in gender-mismatched grafts: amelioration by triple therapy.
Keogh AM; Valantine HA; Hunt SA; Schroeder JS; Oyer PE
J Heart Lung Transplant; 1991; 10(1 Pt 1):106-10. PubMed ID: 2007161
[TBL] [Abstract][Full Text] [Related]
35. Isolated pulmonary rejection after combined heart-lung transplantation.
McGregor CG; Baldwin JC; Jamieson SW; Billingham ME; Yousem SA; Burke CM; Oyer PE; Stinson EB; Shumway NE
J Thorac Cardiovasc Surg; 1985 Oct; 90(4):623-6. PubMed ID: 3930886
[TBL] [Abstract][Full Text] [Related]
36. [Value of a powerful initial immunosuppression after liver transplantation. Prospective study of 60 cases].
Cherqui D; Duvoux C; Charlotte F; Humeres R; Lauzet JY; Métreau JM; Salvat A; Rotman N; Julien M; Fagniez PL
Gastroenterol Clin Biol; 1994; 18(2):115-22. PubMed ID: 8013792
[TBL] [Abstract][Full Text] [Related]
37. Pediatric heart transplantation at St. Christopher's Hospital for Children.
Dunn JM; Cavarocchi NC; Balsara RK; Kolff J; McClurken J; Badellino MM; Vieweg C; Donner RM
J Heart Transplant; 1987; 6(6):334-42. PubMed ID: 3320304
[TBL] [Abstract][Full Text] [Related]
38. Endothelin plasma levels in acute graft rejection after heart transplantation.
Dengler TJ; Zimmermann R; Tiefenbacher CP; Braun K; Sack FU; Kübler W
J Heart Lung Transplant; 1995; 14(6 Pt 1):1057-64. PubMed ID: 8719451
[TBL] [Abstract][Full Text] [Related]
39. Methotrexate for rejection prophylaxis after heart transplantation.
Taylor DO; Olsen SL; Ensley RD; Renlund DG
J Heart Lung Transplant; 1995; 14(5):950-4. PubMed ID: 8800732
[TBL] [Abstract][Full Text] [Related]
40. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.
Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA
J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
